The effect of regular physical activity (PA) on the microcirculatory functions and plasma antioxidant capacity in older athletes.
SpringWorks eyes US filing for MEK inhibitor after positive PhIIb data in rare disease
SpringWorks Therapeutics has unveiled positive data from a mid-stage trial of its drug candidate for neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN), paving the